Form 4 for MEDP Medpace Holdings, Inc.
Accepted 2025-11-26 00:00:00 ET · period of report 2025-11-24 · accession 0001622058-25-000017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-11-26 | 2025-11-24+ | MEDP | Troendle August J. | CEO, Dir, 10% | S - Sale | $611.02 | -101.4K | 732.2K | -12% | -$61.97M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-24 | S | D | 59,025 | $607.78 | 774,602 | D | — | — | (F2) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $593.46 to $617.165. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| 2 | Common | Common Stock | 2025-11-25 | S | D | 42,392 | $615.52 | 732,210 | D | — | — | (F3) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $610.50 to $626.545. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |